It will grow to $26.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /EINPresswire.com/ -- ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

The FDA has approved Yeztugo, a twice-yearly HIV injection by Gilead shown to virtually eliminate new infections.

After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...